[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335260-105":59,"doc-detail-335260-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sema7a-as-a-novel-prognostic-biomarker-and-its-correlation-with-immune-infiltrates-in-breast-cancer","SEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer","","Semaphorin 7a (SEMA7A) has been widely studied in cancer initiation and progression, yet its prognostic value in breast cancer remains unclear. A pancancer evaluation was conducted using The Cancer Genome Atlas and multiple bioinformatics resources, integrating analyses of SEMA7A expression, mutations, immune infiltration patterns, and tumor mutation burden. Kaplan–Meier survival assessment, ROC curve modeling, and nomogram construction demonstrated that high SEMA7A levels associate with poorer overall survival and distant metastasis-free survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sema7a-as-a-novel-prognostic-biomarker-and-its-correlation-with-immune-infiltrates-in-breast-cancer/335260/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sema7a-as-a-novel-prognostic-biomarker-and-its-correlation-with-immune-infiltrates-in-breast-cancer/335260.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main goal regarding SEMA7A in breast cancer?","Question",{"text":112,"@type":113},"To clarify the prognostic significance of SEMA7A in breast cancer and evaluate how it correlates with immune infiltration and tumor mutation burden.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and analysis tools were used to investigate SEMA7A?",{"text":117,"@type":113},"The study analyzed data from The Cancer Genome Atlas, and used tools such as the University of Alabama at Birmingham Cancer data portal, cBioPortal, tumor immune estimation resources, Kaplan–Meier Plotter, and R for ROC curves and nomograms.",{"name":119,"@type":110,"acceptedAnswer":120},"What key prognostic relationship did the results show for breast cancer patients?",{"text":121,"@type":113},"Higher SEMA7A expression was linked to shorter overall survival and distant metastasis-free survival, supporting SEMA7A as a reliable prognostic biomarker for breast cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335260,1791020242,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","International Journal of General Medicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nSEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer  \nShiyu Zhang, Fanting Kong, Lei Zheng, Xiaowei Li, Lining Jia, Lixian Yang  Department of Breast Surgery, Xingtai People’s Hospital, Xingtai, Hebei, 054000, People’s Republic of China  \nCorrespondence: Lixian Yang, Department of Breast Surgery, Xingtai People’s Hospital, No. 818 Xiangdu District, Xingtai, Hebei, 054000, People’s Republic of China, [Email yanglixian@hebmu.edu.cn](Email yanglixian@hebmu.edu.cn)  \n\n| Background: The role of Semaphorin 7a (SEMA7A) in the initiation and progression of different types of cancerous lesions has been extensively studied. However, the prognostic significance of SEMA7A, specifically in breast cancer (BC), lacks clarity.\u003Cbr>Methods: We conducted an evaluation on the relationship between SEMA7A and the prognosis, immune invasion and tumor mutation burden in different types of cancer by analyzing data from The Cancer Genome Atlas database. The present study focused on investigating the expression level, mutation, immune correlation and coexpression of SEMA7A in BC, utilizing various databases such as the University of Alabama at Birmingham Cancer data analysis portal, cBioPortal and tumor immune estimation resource. Survival analysis was carried out using the Kaplan-Meier Plotter. Furthermore, we employed the R software package to generate receiver operating characteristic (ROC) curves and nomograms. Notably, P\u003C0.05 was considered to indicate statistical significance. Results: Using pancancer analysis, it has been observed that the expression of SEMA7A is elevated in various types of cancer and is strongly correlated with the prognosis of different cancer types. SEMA7A also exhibits a significant association with the tumor mutation burden of diverse types of cancer. Moreover, SEMA7A displays a notable increase in BC cases, and was indicated to have a substantial association with the abundance of immune infiltration. In-depth survival analysis demonstrated that elevated levels of\u003Cbr>SEMA7A expression are notably linked to shorter overall survival and distant metastasis-free survival among patients with BC. The efficiency of SEMA7A as a reliable prognostic biomarker for BC has been substantiated by the validation of ROC curves and nomograms.\u003Cbr>Conclusion: SEMA7A has the potential to function as a prognostic indicator for BC, and its correlation with immune infiltration in BC is significant.\u003Cbr>Keywords: SEMA7A, breast cancer, biomarker, prognosis, methylation, immune infiltration, nomogram, bioinformatics |\n| --- |\n| Introduction\u003Cbr>Breast cancer (BC), also known as BRCA, is a prevalent malignancy affecting women worldwide.1 It stands as one of the leading causes of cancer-related deaths and has the highest occurrence rate among all cancers in women.2,3 Current statistics show that BC accounted for approximately 30% of diagnosed cancer cases in women in the United States in 2021.3 The United States was projected to witness 284,200 newly diagnosed cases of BC in 2021, with an estimated 44,130 deaths resulting from this disease.3 Nevertheless, numerous aspects of the precise molecular biological mechanism underlying the onset and progression of BC remain uncertain. Furthermore, the detection rate for early-stage BC is inadequate, and the therapeutic interventions are associated with significant adverse effects, resulting in subpar outcomesin the clinical management of this malignancy.4–6 The biological heterogeneity of patients with BC hampers the ability of the current staging system to accurately predict their prognosis. Additionally, the characteristics of tumor cells can impact the clinical outcome of patients. Exploiting these features to develop prognostic markers may enhance the current TNM staging system, leading to improved clinical p","cbCaieBHDffV8xyE","https://ap.wps.com/l/cbCaieBHDffV8xyE","pdf",13688304,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction\n## Breast cancer overview\n## Need for prognostic biomarkers","[{\"question\":\"What was the study’s main goal regarding SEMA7A in breast cancer?\",\"answer\":\"To clarify the prognostic significance of SEMA7A in breast cancer and evaluate how it correlates with immune infiltration and tumor mutation burden.\"},{\"question\":\"Which databases and analysis tools were used to investigate SEMA7A?\",\"answer\":\"The study analyzed data from The Cancer Genome Atlas, and used tools such as the University of Alabama at Birmingham Cancer data portal, cBioPortal, tumor immune estimation resources, Kaplan–Meier Plotter, and R for ROC curves and nomograms.\"},{\"question\":\"What key prognostic relationship did the results show for breast cancer patients?\",\"answer\":\"Higher SEMA7A expression was linked to shorter overall survival and distant metastasis-free survival, supporting SEMA7A as a reliable prognostic biomarker for breast cancer.\"}]","SEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer | PDF",1790010324,48]